NCT02600780View on ClinicalTrials.gov

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions

Hyperuricemia

Interventions

DRUG

Febuxostat

Comparison of two anti-hyperuricemic molecules

DRUG

Allopurinol

Comparison of two anti-hyperuricemic molecules

Trial Locations (1)

74900

Dow University of Health Sciences, Karachi

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Getz Pharma

INDUSTRY